Lepper, A. (2025). The study on myeloid-derived suppressor cells (MDSCs) and T cells in melanoma patients with adverse events after immunotherapy immune checkpoint inhibitors. https://doi.org/10.11588/heidok.00036613
Chicago Style (17th ed.) CitationLepper, Alisa. The Study on Myeloid-derived Suppressor Cells (MDSCs) and T Cells in Melanoma Patients with Adverse Events After Immunotherapy Immune Checkpoint Inhibitors. Heidelberg, 2025. https://doi.org/10.11588/heidok.00036613.
MLA (9th ed.) CitationLepper, Alisa. The Study on Myeloid-derived Suppressor Cells (MDSCs) and T Cells in Melanoma Patients with Adverse Events After Immunotherapy Immune Checkpoint Inhibitors. 2025. https://doi.org/10.11588/heidok.00036613.
Warning: These citations may not always be 100% accurate.